Paladin Labs Inc., of Montreal, granted Takeda Pharmaceutical Co. Ltd., of Osaka, Japan, an exclusive right to develop and commercialize fomepizole (marketed as Antizol in Canada and the U.S.) for the treatment of ethylene glycol and methanol poisonings in Japan.